Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Iris Y Navarro-Millán

Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial

scientific article published on 25 November 2015

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration

scientific article

Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment

scientific article published on 11 April 2018

Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

scientific article published on June 2013

Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.

scientific article published on 15 April 2013

Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability

scientific article

Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data.

scientific article

Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial

scientific article published on 2 August 2016

Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis

scientific article published on May 2013

Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient Reported Outcome Data Collection: A Qualitative Study.

scientific article published on 18 April 2018

Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial

scientific article published on October 13, 2011

Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients.

scientific article

Reconstructing the population history of Puerto Rico by means of mtDNA phylogeographic analysis

scientific article

Reply - "Anakinra for COVID-19: how to interpret elevations in liver enzymes"

scientific article published on 20 September 2020

Screening of Hyperlipidemia among Patients with Rheumatoid Arthritis in the United States

scientific article published on 01 December 2019

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor

scientific article

Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis

scientific article published on 22 October 2013

Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group

scientific article published on 15 January 2019

Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood

scientific article published on 01 July 2011

Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series

scientific article published on 30 June 2020

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal

scientific article

Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis

scientific article published on 05 March 2020

Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?

scientific article published on 05 September 2019